Bateman RJ - Search Results

1

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly Inherited Alzheimer Network. Bateman RJ, et al. N Engl J Med. 2012 Aug 30;367(9):795-804. doi: 10.1056/NEJMoa1202753. Epub 2012 Jul 11. N Engl J Med. 2012. PMID: 22784036 Free PMC article.

2

Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

Yan P, Hu X, Song H, Yin K, Bateman RJ, Cirrito JR, Xiao Q, Hsu FF, Turk JW, Xu J, Hsu CY, Holtzman DM, Lee JM. Yan P, et al. Among authors: bateman rj. J Biol Chem. 2006 Aug 25;281(34):24566-74. doi: 10.1074/jbc.M602440200. Epub 2006 Jun 20. J Biol Chem. 2006. PMID: 16787929 Free article.

3

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.

Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Bateman RJ, et al. Nat Med. 2006 Jul;12(7):856-61. doi: 10.1038/nm1438. Epub 2006 Jun 25. Nat Med. 2006. PMID: 16799555 Free PMC article.

4

Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism.

Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM. Yin KJ, et al. J Neurosci. 2006 Oct 25;26(43):10939-48. doi: 10.1523/JNEUROSCI.2085-06.2006. J Neurosci. 2006. PMID: 17065436 Free PMC article.

5

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

Bateman RJ, Wen G, Morris JC, Holtzman DM. Bateman RJ, et al. Neurology. 2007 Feb 27;68(9):666-9. doi: 10.1212/01.wnl.0000256043.50901.e3. Neurology. 2007. PMID: 17325273

6

Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates.

Bateman RJ, Munsell LY, Chen X, Holtzman DM, Yarasheski KE. Bateman RJ, et al. J Am Soc Mass Spectrom. 2007 Jun;18(6):997-1006. doi: 10.1016/j.jasms.2007.02.009. Epub 2007 Feb 22. J Am Soc Mass Spectrom. 2007. PMID: 17383190 Free PMC article.

7

Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.

Bateman RJ, Klunk WE. Bateman RJ, et al. Neurotherapeutics. 2008 Jul;5(3):381-90. doi: 10.1016/j.nurt.2008.05.009. Neurotherapeutics. 2008. PMID: 18625449 Free PMC article. Review.

8

A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.

Bateman RJ, Siemers ER, Mawuenyega KG, Wen G, Browning KR, Sigurdson WC, Yarasheski KE, Friedrich SW, Demattos RB, May PC, Paul SM, Holtzman DM. Bateman RJ, et al. Ann Neurol. 2009 Jul;66(1):48-54. doi: 10.1002/ana.21623. Ann Neurol. 2009. PMID: 19360898 Free PMC article. Clinical Trial.

9

Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.

Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM. Kang JE, et al. Among authors: bateman rj. Science. 2009 Nov 13;326(5955):1005-7. doi: 10.1126/science.1180962. Epub 2009 Sep 24. Science. 2009. PMID: 19779148 Free PMC article.

10

Decreased clearance of CNS beta-amyloid in Alzheimer's disease.

Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ. Mawuenyega KG, et al. Among authors: bateman rj. Science. 2010 Dec 24;330(6012):1774. doi: 10.1126/science.1197623. Epub 2010 Dec 9. Science. 2010. PMID: 21148344 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page